The rate of serious infections of 5.7/100 patient-years after 612 patient-years of treatment was comparable to that reported with tumour necrosis factor (TNF) antagonists.16, 17 There was no systemic opportunistic infection or tuberculosis in this study. The gene discussed is TNF; the disease is infection.